指南与共识头颈外科小儿耳鼻咽喉

HPV疫苗接种趋势及其与不断演变推荐的一致性评估

Assessing HPV Vaccination Trends and Their Alignment with Evolving Recommendations.
指南 / 共识 · Otolaryngol Head Neck Surg · 2026-06-03

研究发现扩大推荐范围对接种趋势影响不一致:男性9至21岁接种在2010至2016年增长836%,但2016至2023年9至26岁总接种下降47.1%,接种科室日趋多样化但仍以儿科为主。

要点

  • 2009年纳入9至21岁男性后,该组2010至2016年接种量增长836%。
  • 2016至2023年9至26岁患者总接种量下降47.1%,尽管适应证已扩大。
  • 2023年儿科接种占46.6%,家庭医学33.3%,妇产科7.1%,初级保健6.8%。

核心结论

  • 扩大指南对接种趋势影响不一致,2016年以来目标人群接种率下降。
  • 男性在儿科接种中占比与女性相当,但在成人接种中不然。
  • 接种科室日趋多样化,但儿科仍占主导。

研究设计与样本

  • 横断面研究,分析2007至2023年接种趋势。
  • 数据来自Epic Cosmos全国数据库,覆盖美国医院和诊所。
  • 纳入9至45岁患者,按年份、人口学和接种提供者科室分层。

主要发现

  • 2009年起推荐纳入9至21岁男性,该组接种量从2010至2016年增长836%。
  • 2023年9至18岁接种者中男性占49.9%,自2010年以来逐年上升。
  • 2020年头颈癌预防成为指定疫苗适应证。
  • 2016至2023年9至26岁患者总接种量下降47.1%。
  • 2012年儿科接种占74.8%、家庭医学18.3%;2023年儿科46.6%、家庭医学33.3%、妇产科7.1%、初级保健6.8%。

关键数值与推荐

  • 2009年起推荐纳入9至21岁男性接种HPV疫苗。
  • 2020年头颈癌预防成为指定疫苗适应证。

临床怎么用

  • 应关注2016年以来目标人群接种下降趋势,加强接种促进。
  • 成人接种中男性参与不足,需针对性教育。
  • 接种科室多样化提示非儿科科室应参与HPV疫苗接种。
  • 性别化和过时的教育与宣传可能加剧差异,需更新宣教内容。

局限性

  • 原文未报告。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: HPV vaccination recommendations have expanded to include both sexes and a broadened age range since approval in 2006. These changes and increasing HPV-related head and neck cancer rates support vaccination of older and male patients, necessitating changes in HPV education. We aim to analyze vaccination trends and to identify opportunities for increasing awareness. STUDY DESIGN: Cross-sectional study analyzing vaccination trends between 2007 and 2023. SETTING: US hospitals and clinics using Epic. METHODS: Using Epic Cosmos, a national database, vaccination trends for patients aged 9 to 45 were stratified by year, demographics, and administering provider specialty. RESULTS: 19.6 million HPV vaccinations were administered between 2007 and 2023. The inclusion of males aged 9 to 21 in the recommendations beginning in 2009 corresponded with an 836% increase in vaccinations in this group from 2010 to 2016. Males comprised 49.9% of vaccinated patients aged 9 to 18 in 2023, a percentage that increased annually since 2010. Head and neck cancer prevention became a designated vaccine indication in 2020. Despite broadened indications, total vaccination declined by 47.1% from 2016 to 2023 in patients aged 9 to 26. In 2012, 74.8% of vaccinations were administered in pediatrics and 18.3% in family medicine. In 2023, pediatrics administered 46.6%, family medicine 33.3%, OBGYN 7.1%, and primary care 6.8%. CONCLUSION: Expanding guidelines have had inconsistent impacts on vaccination trends, as rates decreased in target populations since 2016. Males contribute equally to pediatric but not adult vaccinations. Departments administering vaccines are diversifying, though pediatrics predominates. Gendered and outdated education and marketing could contribute to disparities and discordance with guidelines.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Loheide SE, Lee BM, Taufique ZM, et al. Assessing HPV Vaccination Trends and Their Alignment with Evolving Recommendations. Otolaryngol Head Neck Surg. 2026. PMID: 42233631. doi:10.1002/ohn.70310

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。